The Evolving Treatment Landscape in Light Chain Amyloidosis with Cardiac Involvement - Episode 8

Ongoing AFFIRM-AL Trial Background, Patient Eligibility, and Active Enrollment

,

Dr. Kumar and Dr. Zonder discuss the ongoing confirmatory Phase III AFFIRM-AL trial investigating the efficacy and safety of birtamimab and ongoing recruitment in the trial.